EurekAlert! -
24 Jan 2020 07:00
(McGill University) In a new study, a team of researchers at McGill University has shown that, when given in a formulation that facilitates passage to the brain, lithium in doses up to 400 times lower than what is currently being prescribed for mood disorders is capable of both halting signs of advanced Alzheimer's pathology and of recovering lost cognitive abilities.
Share this Article
Comment on this Article
Please to comment